Sangamo Therapeutics Received U.S. FDA Fast Track Designation for ST-503 for the Treatment of Small Fiber Neuropathy

Therapeutic Applications

Therapeutic Applications

Using our highly versatile zinc finger platform, we are designing and developing genomic medicines to potentially transform the lives of patients suffering from severe diseases.

Our technology can be utilized to potentially address a wide range of therapeutic applications. Our primary focus areas are:

Neurology
Autoimmunity
Oncology

Latest Publications & Presentations